Prospects and challenges for the development of new therapies for Ewing sarcoma.

Grohar PJ, Helman LJ
Pharmacol Ther. 2013 137 (2): 216-24

PMID: 23085431 · PMCID: PMC7243921 · DOI:10.1016/j.pharmthera.2012.10.004

MeSH Terms (13)

Antineoplastic Agents Bone Neoplasms Camptothecin Clinical Trials as Topic Dioxoles Epigenesis, Genetic Humans Molecular Targeted Therapy Poly(ADP-ribose) Polymerase Inhibitors Sarcoma, Ewing Somatomedins Tetrahydroisoquinolines Trabectedin

Connections (2)

This publication is referenced by other Labnodes entities: